With the surge in cases of influenza-like illnesses in Sri Lanka, medical experts are expressing concerns about the possible presence of JN.1, a sub-lineage of the Omicron variant, within the community.
Despite this, experts are quick to dismiss any immediate threat, citing Sri Lanka’s successful management of previous waves and the country’s preparedness for a potential increase in cases.
Professor Chandima Jeewandara, Head of the Department of Immunology and Molecular Medicine and Director of the Allergy Immunology and Cell Biology Unit at the Faculty of Medical Sciences, University of Sri Jayewardenepura, highlighted the lack of extensive testing in Sri Lanka, making it challenging to assess the current situation accurately. He emphasized that the JN.1 sub-variant may already be present, given the observed uptick in influenza-like illnesses.
Prof. Jeewandara emphasized the complexity of COVID-19 compared to the common cold, underscoring the potential for severe illness and long-term effects. He advised heightened vigilance, particularly for individuals aged 60 and above, those with compromised immunity, and individuals with comorbidities, recommending the use of masks in certain environments.
Furthermore, he urged individuals experiencing symptoms such as fever, cough, loss of smell and taste, high fever, breathing difficulties, fatigue, inability to eat, and vomiting tendencies to seek medical care promptly.
Dr. Anwar Hamdani, the Sri Lanka COVID-19 Coordinator, reassured the public that the Ministry is closely monitoring the situation.
The JN.1 variant, identified as a sub-variant of Omicron BA.2.86 or Pirola, was first detected in the United States in September 2023. Notably, China reported seven infections of this subvariant on December 15, as per a Reuters report.
